More articles from 261. Treatment of human pulmonary hypertension

Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease
Nazzareno Galie, Robyn Barst, Bruce Brundage, Hossein A. Ghofrani, Ronald Oudiz, Gerald Simonneau

European Respiratory Journal Sep 2011, 38 (Suppl 55) p2299;
Double combination therapy in patients with pulmonary arterial hypertension associated with connective tissue disease
Enrico Gotti, Enri Leci, Alessandra Manes, Massimiliano Palazzini, Elena Beciani, Elisa Conficoni, Nicole Rizzo, Francesca Terzi, Gaia Mazzanti, Francesca Sciarra, Nazzareno Galiè

European Respiratory Journal Sep 2011, 38 (Suppl 55) p2298;
Everolimus improves exercise capacity and pulmonary vascular resistance in patients with advanced pulmonary hypertension – A pilot study
Hans-Juergen Seyfarth, Stefan Hammerschmidt, Michael Halank, Petra Neuhaus, Hubert Wirtz

European Respiratory Journal Sep 2011, 38 (Suppl 55) p2295;
Pulmonary hypertension in patients treated with Src/Abl kinase inhibitor dasatinib
David Montani, Emmanuel Bergot, Sven Günther, Laurent Savale, Anne Bergeron, Arnaud Bourdin, Hélène Bouvaist, Mathieu Canuet, Christophe Pison, Margaret Macro, Patrice Poubeau, Delphine Natali, Frederic Perros, Dermot S. O'Callaghan, Xavier Jaïs, Gérard Zalcman, Olivier Sitbon, Gérald Simonneau, Marc Humbert

European Respiratory Journal Sep 2011, 38 (Suppl 55) p2294;
Ambrisentan improves exercise capacity and symptoms in patients with portopulmonary hypertension
Michael Halank, Lars Knudsen, Hans-Juergen Seyfarth, Ralf Ewert, Baerbel Wiedemann, Martin Kolditz, Gert Hoeffken, Marius Hoeper

European Respiratory Journal Sep 2011, 38 (Suppl 55) p2297;
First and second line treatment pattern among pulmonary hypertension patients enrolled in a managed care health plan
Vijay Joish, David Muccino, Charles Krelick

European Respiratory Journal Sep 2011, 38 (Suppl 55) p2293;
Optimization of tissue targeting properties of macitentan, a new dual endothelin receptor antagonist, improves its efficacy in a rat model of pulmonary fibrosis associated with pulmonary arterial hypertension
Marc Iglarz, Kyle Landskroner, Daniel Wanner, Markus Rey, Patrick Hess, Martine Clozel

European Respiratory Journal Sep 2011, 38 (Suppl 55) p2292;
Effects of BAY 41-8543 and sildenafil on right heart structure and function in pulmonary artery banded mice
Wiebke Janssen, Yves Schymura, Astrid Wietelmann, Johannes-Peter Stasch, Himal Luitel, Norbert Weissmann, Hossein Ardeschir Ghofrani, Friedrich Grimminger, Thomas Braun, Werner Seeger, Ralph Theo Schermuly

European Respiratory Journal Sep 2011, 38 (Suppl 55) p2290;
Comparison of different vasodilators in a model of secondary pulmonary hypertension (PH): Desaturation effects
Eva Maria Becker, Johannes-Peter Stasch, Martin Bechem, Raimund Kast, Hubert Truebel

European Respiratory Journal Sep 2011, 38 (Suppl 55) p2291;
Cure pulmonary arterial hypertension associated with HIV (PAH-HIV)? ... Toward an answer
Colas Tcherakian, Elisabeth Rivaud, Anne-Cécile Metivier, Emilie Catherinot, David Zucman, Louis-Jean Couderc

European Respiratory Journal Sep 2011, 38 (Suppl 55) p2289;

Main menu

User menu

Search

More articles from 261. Treatment of human pulmonary hypertension

Pages

Contact us